This activity already occurred and is no longer available.
JNM (November 2013) The Role of Radionuclide Imaging in Epilepsy, Part 2: Epilepsy Syndromes
JNM, November 2013. Volume 54, Number 11

JNM (November 2013) The Role of Radionuclide Imaging in Epilepsy, Part 2: Epilepsy Syndromes 
JNM, November 2013, Volume 54, Number 11

Member Fee: Free
Non-Member Fee: $15.00

Release Date: November 1, 2013
Expiration Date: November 31, 2016


Authors
Ajay Kumar and Harry T. Chugani
PET Center, Department of Pediatrics, Neurology, and Radiology, Children’s Hospital of Michigan, Detroit Medical Center, Wayne State University School of Medicine, Detroit, Michigan

Financial Disclosure
The authors of this article have indicated no relevant relationships that could be perceived as a real or apparent conflict of interest.

Target Audience

Physicians, pharmacists, and technologists and any professionals in the nuclear medicine and related fields.

Objectives
At the completion of this activity, the participant will be able to:
1. Describe the role of radionuclide imaging, using PET and SPECT, in evaluating patients with various epilepsy syndromes, particularly those with unknown causes, by revealing underlying brain abnormalities and the possible etiopathogenesis; 
2. Describe the role of radionuclide imaging in guiding treatment selection, including surgical treatments; and 
3. Describe the role of radionuclide imaging monitoring disease progression and providing useful prognostic information.


Continuing Education Credit Information

AMA-PRA (Physician)
The Society for Nuclear Medicine and Medical Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

SNMMI designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity. To receive CE credit, learners must achieve a score of 80% on the post-course assessment and complete the evaluation. Release date: November 1, 2013 Expiration date: November 31, 2016.

 
ACPE (Pharmacists)
The Society for Nuclear Medicine and Molecular Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been designated as knowledge-based CPE. The universal program number for this enduring material is 0210-0000-13-314-H04-P. Total available credit for pharmacists is 1.0 hours or 0.10 CEUs. Release Date: November 1, 2013 Expiration date: November 31, 2016. To receive CE credit, learners must achieve a score of 80% on the post-course assessment and complete the evaluation.

VOICE (Technologists)
The SNMMI, through its Verification of Involvement in Continuing Education (VOICE) program, has approved this journal article for a maximum of 1.0 continuing education hours (CEHs). VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT as Category A credit. Participants will receive CE credit for those sessions at which they were present a minimum of 80%. Release Date: November 1, 2013. Expiration Date:  November, 2016. California Scope: 0.5 Imaging(I), 0.5 (R) Radiotherapy.

Minimum system requirements


Supported Internet Browsers:
- Microsoft Internet Explorer (version 7 or higher)
- Google Chrome (latest version)
- Mozilla Firefox (latest version)
- Apple Safari (version 4 or higher)

Plug-in: Adobe Acrobat Reader (http://get.adobe.com/reader/)

For questions please contact the Education Department at Education@snmmi.org 

© 2014 SNMMI. All rights reserved.     


Type:     Internet Activity (Enduring Material)
963 Registered Users